Global Ophthalmology PACS Market, by Type (Integrated PACS and Standalone PACS), by Delivery Model (Cloud-Based Model and On-Premise Model), by End User (Hospitals and Speciality Clinics), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 201.18 million in 2022 and is expected to exhibit a CAGR of 5.9% during the forecast period (2022-2030).
Market players are involved in launching cloud-based service for medical imaging PACS, which is expected to drive the growth of the global ophthalmology PACS market over the forecast period. For instance, on November 29, 2021, Change Healthcare, a healthcare technology company, had launched Stratus Imaging PACS, a cloud-native, zero-footprint PACS for medical use. Stratus Imaging PACS offers a continuous solution for medical practices to have access to images from different locations such as hospitals and clinics, as well as from home, on one platform. This is expected to drive to global ophthalmology PACS market growth.
Market players are engaged in inorganic activities such as partnerships, and this is expected to drive the growth of the global ophthalmology PACS market over the forecast period. For instance, on July 21, 2021, Intelerad Medical Systems, a medical image management company, had announced a partnership agreement with LifeBridge Health, a healthcare company, to provide cloud-based medical imaging managed services. The partnership aims to enhance the workflow and productivity and ensure the protection of patients’ data.
Global Ophthalmology PACS Market - Impact of Coronavirus (COVID-19) Pandemic
The coronavirus disease (COVID-19) pandemic is expected to hamper the growth of the global ophthalmology PACS market over the forecast period. COVID-19 is the recent pandemic outbreak, which was first reported on December 31, 2019 in Wuhan, China. The World Health Organization declared coronavirus disease (COVID-19) a pandemic on March 11, 2020. According to the World Health Organization (WHO) Weekly epidemiological update on COVID-19, the number of new cases remained stable during the week of 1 to 7 August 2022 Therefore, as of August 7, 2022, 581.8 million confirmed cases and 6.4 million deaths have been reported globally.
Governments of different countries had imposed complete lockdown to control the spread of COVID-19 virus that has resulted in restriction in transportation and people movement, loss of jobs, etc. Due to restriction in transportation and people movement during the COVID-19 pandemic, companies faced difficulties and had to stop the installation of new hardware system in medical care centers. This has hampered the growth of the global ophthalmology PACS market during the pandemic.
Browse 29 Market Data Tables and 38 Figures spread through 302 Pages and in-depth TOC on Global Ophthalmology PACS Market, by type (Integrated PACS and Standalone PACS), by Delivery Model (Cloud-Based Model and On-Premise Model), by End User (Hospitals and Speciality Clinics), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in the global ophthalmology PACS market, click the link below:
https://www.coherentmarketinsights.com/market-insight/ophthalmology-pacs-market-5269
Market players are launching artificial intelligence-enabled transformative systems to be used for medicinal purpose, which is expected to drive the global ophthalmology PACS market growth over the forecast period. For instance, on August 9, 2021, GE Healthcare, a developer of health information technology, launched Edison True PACS, a transformative system that offers artificial intelligence-enabled decision support. Edison True PACS helps radiologist adjust high work load and increase accuracy for diagnostics.
Key Takeaways of the Ophthalmology PACS Market:
- The global ophthalmology PACS market is expected to exhibit a CAGR of 5.9% over the forecast period (2022-2030), owing to significant growth in potential markets, especially in Europe, while North America accounted for the major market share.
- Market players are engaged in improving the data security for PACS systems, which is expected to drive the growth of the global ophthalmology PACS market over the forecast period. For instance, on May 26, 2022, ScImage, Inc., a software company, had completed its report SOC 2 Type 1 to enhance the data security for PACS according to standards established by the American Institute of Certified Public Accountants (AICPA).
- Major players operating in the global ophthalmology PACS market include Topcon Corporation, Agfa-Gevaert N.V., Sonomed Escalon, Carl Zeiss Meditec AG, EyePACS, VersaSuite, Heidelberg Engineering GmbH, ScImage, Inc., IBM Corporation, and Visbion Limited
